Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Roche Pharma AG"
Count: 408
Selected: 0
NCT IDTitle
NCT04557813Registry for Molecular Testing, Treatment and Outcome of Patients With Solid Tumors Harboring a NTRK Gene Fusion
NCT03911219Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy
NCT04335071Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)
NCT02716779Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection
NCT02739594Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma
NCT04332822A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
NCT04245085ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma
NCT05057234PRecision Oncology Evidence Development in Cancer Treatment - Liquid
NCT05075538COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2
NCT00676715A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
NCT06191068Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With Hemophilia
NCT05733611RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC
NCT05733598RP3 in Combination With 1L or 2L Therapy in Patients With Locally Advanced Unresectable or Metastatic HCC
NCT05050214Obinutuzumab in Primary MN
NCT04363853Tocilizumab Treatment in Patients With COVID-19
NCT05300282Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
NCT04497116Study of RP-3500, Camonsertib, in Advanced Solid Tumors
NCT05966233R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma
NCT05839145Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study
NCT03341520Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma
NCT05464368R21 Roche: 3-Way Tau Tracers in AD
NCT03449914The GOLD Study: G8 in OLDer Patients
NCT05825261Exploring Novel Biomarkers for Emphysema Detection
NCT04602078Study of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial Carcinoma
NCT03697850Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy
NCT04972110Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors
NCT05470595A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung
NCT04984811NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC
NCT02899065Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department
NCT03721653FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients
NCT04148066ctDNA Guided Treatment of Early Resistance to Targeted Treatment
NCT06068998Molecular Characterization of Penile Cancers in Developing Countries
NCT03519295A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma
NCT04611867Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)
NCT02708680Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In
NCT05929222Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi
NCT06008691A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
NCT03229382Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse
NCT03961698Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma
NCT03421288Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune Responsiveness
NCT01565200HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1
NCT00079053Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT05975242Acceptability & Impact of a Diabetes Management Smartphone App (mySugr) for Spanish-literate Adults With Type 2 Diabetes
NCT04437628Prognostic Value Of Short-Term Follow-up Biomarkers After Discharge In hOspitalized Patients With Acute Heart Failure
NCT04484636PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)
NCT03779191Alectinib in Combination With Bevacizumab in ALK Positive NSCLC
NCT04947605Epidemiological Landscape of Cervical Cancer in Latin America
NCT05911178Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease
NCT04653831Treatment With Pirfenidone for COVID-19 Related Severe ARDS
NCT05283044Implementing Precision Medicine in cOmmunity HospiTALs